Journal Article DKFZ-2023-02497

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2

 ;  ;  ;

2023
Frontiers Media Lausanne

Frontiers in immunology 14, 1272018 () [10.3389/fimmu.2023.1272018]
 GO

This record in other databases:

Please use a persistent id in citations: doi:

Classification:

Note: #EA:F035#LA:F035# / EMBL-DKFZ Chemical Biology Core Facility

Contributing Institute(s):
  1. Tumorvirus-spez. Vakzinierungsstrategie (F035)
  2. Gruppe Sehr EMBL (W040)
Research Program(s):
  1. 316 - Infektionen, Entzündung und Krebs (POF4-316) (POF4-316)

Appears in the scientific report 2023
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2023-11-29, last modified 2024-03-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)